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Abstract: Epidemiological studies have demonstrated higher frequencies of the O blood group 
and the nonsecretor phenotype of ABH antigens among patients suffering from peptic ulcers. 
Since Helicobacter pylori has been established as the main etiological factor in this disease, con-
troversies about the associations of the ABO and Lewis blood group phenotypes and secretor and 
nonsecretor phenotypes in relation to susceptibility towards infection by this bacillus have been 
presented. The aim of this study was to verify the frequencies of ABO and Rhesus (Rh) blood 
groups in H. pylori seropositive symptomatic patients. The study included (n = 1108) patients 
with dyspepsia symptoms referred from an outpatient clinic in Erbil city for investigation. Age, 
sex, and residency were recorded as a routine laboratory framework. Patients underwent SD Bio-
line (Standard Diagnostics Inc, Kyonggi-do, South Korea) and enzyme-linked immunosorbent 
assay serologic tests for H. pylori. ABO blood group phenotypes were determined by a standard 
hemagglutination test. Results showed that 64.8% of patients (n = 718/1108) were seropositive for 
H. pylori infection, and (35.2%) (n = 390/1108) were seronegative. Of the seropositive patients, 
40.8% (n = 293/718) were male and 59.2% (n = 425/718) were female; while of the seronegative 
patients, 46.7% (n = 182/390) were male and 53.3% (n = 208/390) were female. The mean age 
for seropositives and seronegatives was (38.0 ± 14.6) years and (37.6 ± 15.7) years respectively. 
The frequency of the ABO and Rh-positive (Rh+) blood groups among seropositive patients was 
(A = 32.0%, B = 19.5%, AB = 6.7%, O = 41.8%, and Rh+ = 92.5%) and was (A = 32.3%, B = 28.2%, 
AB = 8.0%, O = 31.5%, and Rh+ = 92.5%) in seronegatives. The results of this study suggest that 
ABO blood groups, age, and gender influence seropositivity for H. pylori infection.
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Introduction
The association of ABO blood groups with some infectious and noninfectious diseases 
has been described.1,2
Before Helicobacter pylori identification as the main etiology of peptic ulcers, 
chronic gastritis, and a variety of gastrointestinal symptoms,3–5 many epidemiologic 
studies had found that nonsecretors of ABO blood group antigens and individuals of 
blood group O were overrepresented among patients with peptic ulcers.6–8
These studies encouraged many researchers to investigate the relation between 
ABO blood groups and their secretor status with peptic ulcer. Many authors report an 
association between blood group O and H. pylori infection,9–13 while others failed to 
find such an association.14–16
Many methods are used in clinical practice to diagnose H. pylori infection, includ-
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  immunosorbent assay (ELISA)17 and Helisal rapid blood 
(HRB) test, which is a reliable, rapid, and inexpensive screen-
ing test of H. pylori used in epidemiological studies with 
greatest usefulness as a primary office diagnostic device.18
There were no local data on the epidemiology of H. pylori 
infection in the Kurdistan region of Iraq; therefore, the aim of 
this study was to verify the incidence of seropositive H. pylori 
infection among patients with dyspepsia symptoms and to 
verify the frequencies of ABO blood groups in H. pylori 
seropositive symptomatic patients.
Subjects and methods
subjects
From February 2010 to March 2011, a total of 1108 patients 
with the symptoms of dyspepsia or other symptoms refer-
able to the proximal alimentary tract, from an enterology 
outpatient clinic, were referred for serologic diagnosis of 
H. pylori infection. The study was performed according to 
the local Ethical Committee of Medical Sciences.
From each patient, a sample of 3 mL of peripheral blood 
was collected and centrifuged, and the sera were separated 
for use.
Methods
This study was a prospective study of patients attending 
the outpatient clinic for symptoms of dyspepsia for the 
first time, with no previous history of H. pylori infection 
and treatment. The study population was screened for 
H. pylori infection by SD Bioline H. pylori, a rapid HRB 
kit (MT Promedt Consulting GmbH, Ingbert, Germany) to 
receive treatment. For this research purpose, the positive SD 
Bioline H. pylori screening test results were confirmed, by 
estimating the serum levels of anti-H. pylori IgG, using the 
commercial ELISA (Trinity Biotech, Wicklow, Ireland).17 
The results by this method were obtained as immune status 
ratio (ISR), and values of $1.1 were considered positive. 
Those patients who were positive for H. pylori infection by 
both methods were included in the seropositives, those who 
were negative by both methods were regarded as seronega-
tive, and the rest (n = 38) were not included within the total 
study population (n = 1108).
ABO and Rhesus (Rh) blood groups were determined for 
seropositive and seronegative patients, using standardized 
hemagglutination methods.
The results of this study (seropositives) were compared 
with the seronegative patient group and with the author’s pre-
vious study on the ABO blood group frequency in the region,19 
as controls for both age and sex, and blood groups.
statistical analysis
Data generated from this study were analyzed using Sta-
tistical Package for Social Sciences (SPSS) (Chicago, IL). 
Chi square test was used to detect statistically significant 
differences among variables. P-values 0.05 were consid-
ered significant.
Results
The seropositivity for H. pylori infection was present in 
718/1108 (64.8%) and absent in 390/1108 (35.2%) of these 
patients (by both methods). Only in 38 patients, there was dis-
agreement between two tests (ie, an agreement of 95%), and 
these patients were not included in the study population.
The mean age of seropositive patients was (37.99 ± 14.6) 
years (range, 18–82 years), with a median age of 38.4 years 
and no significant difference from the mean age of sero-
negatives (37.6 ± 15.7) years (range, 18–70 years). There 
was a significant increase in the incidence of seropositivity 
up to the age of 31 years (r = 0.91, P = 0) (Figure 1) then a 
significant decline in the incidence above the age of 31 years 
(−r = −0.94, P = 0).
Of these 718 seropositive patients, 37.7% (271/718) 
were male (M) and 62.3% (447/718) were female (F) (M/F 
ratio 0.61:1.0). A significant difference was observed when 
comparing gender in H. pylori infection (P  0.0001) with 
that of the general population (M/F ratio, 1.14:1.0) (Table 1) 
and with seronegative patients (M/F ratio, 1.2:1.0) (Table 2) 
but to a lesser degree (P = 0.0148).
When the frequencies of blood group phenotypes were 
analyzed separately in the seropositive patients, seronega-
tive patients, and the general population, it was possible to 
verify that the frequency of blood group O in seropositive 
patients was higher and blood group B was lower than in 
the general population and to a lesser degree in seronega-
tive patients.
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Table 1 Gender and blood group relation to Helicobacter pylori infected patients compared with the general population
Characteristic Seropositive  
N = 718/1108 (64.8%)
General population14  
N = 53,234
P-value
sex (M/F) 293/425 
M: 40.8% 
F: 59.2%
0.69:1.00 28379/24855 
M: 53.3% 
F: 46.7%
1.14/1.00 0.0001
Blood group
A 230 32.0% 17,283 32.47% 0.811
B 140 19.5% 12,693 23.84% 0.007
AB 48 6.7% 3475 6.53% 0.880
O 300 41.8% 19,783 37.16% 0.011
rhesus positive 664 92.5% 48,833 91.73% 0.497
rhesus negative 54 7.5% 4401 8.27 0.497
Total 718 53,234
Abbreviations: F, female; M, male.
Table  2  Gender  and  blood  group  relation  to  Helicobacter  pylori  infection  in  seropositive  patients  compared  with  seronegative 
patients
Characteristic Seropositives  
N = 718/1108 (64.8%)
Seronegatives  
N = 390/1108 (35.2%)
P-value
sex (M/F) 293/425 
M: 40.8% 
F: 59.2%
0.69:1.00 213/177 
M: 54.6% 
F: 45.4%
1.2/1.0 0.0148
Blood group
A 230 32.0% 126 32.3% 0.936
B 140 19.5% 110 28.2% 0.0495
AB 48 6.7% 31 8.0% 0.663
O 300 41.8% 19,783 31.5% 0.0397
rhesus positive 664 92.5% 349 89.5% 0.288
rhesus negative 54 7.5% 41 10.5% 0.288
Total 718 390
Abbreviations: F, female; M, male.
ABO and Rh blood group frequencies in seropositive and 
seronegative patients are shown in Tables 1 and 2.
These differences between the higher prevalence of type O 
and the lower prevalence of blood group B in the seropositive 
patients compared with that in the general population were 
statistically significant, with P-values of 0.01 and 0.007 
respectively, and also when compared with that in seronegative 
patients with P-values of 0.0397 and 0.0495 respectively.
No significant differences in the frequency of ABO and 
Rh blood groups were observed in different ages in sero-
positive patients. There was also no significant difference in 
Rh+ frequency between seropositive patients, seronegative 
patients, and the general population (Tables 1 and 2).
Discussion
Results of this study showed a significant association 
between the O blood group and infection caused by H. pylori 
(P = 0.01), a finding which is reinforced by data obtained 
from many other studies.9–13
Blood group B patients in this study were less prone to 
H. pylori infection than other blood groups (P = 0.007) – a 
finding not observed in other studies, to the best of the 
author’s knowledge. In another study, AB blood group 
individuals were less prone to H. pylori infection.9
The findings of this present study support the 
epidemiological view of the greater susceptibility of blood 
group O to infection by H. pylori, as well as support the 
conclusions of Alkout et al,20 who demonstrated that the 
H antigen represents an important receptor expressed 
in the gastroduodenal mucosal cells to which H. pylori 
adheres. The findings of this present study disagree 
with some previous studies which demonstrated that the 
O blood group did not represent a risk factor for H. pylori 
infection.15–17
In the author’s view, this discrepancy could be the result 
mainly of the type of the control population they used 
and/or to the surveys which were done in asymptomatic 
individuals16,20,21 rather than symptomatic patients.Clinical and Experimental Gastroenterology 2011:4 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
224
Jaff
This present study used two methods to diagnose H. pylori 
infection serologically to avoid, at least to some extent, some 
other authors’ claims that this discrepancy could be due to 
different methods used to detect H. pylori infection.15–17,22
For example, some authors who have used polymerase 
chain reaction (PCR) stress that other tests employed in the 
diagnosis of H. pylori infection differ in specificity and sen-
sitivity from the PCR method, and may have an influence on 
the different infection frequencies observed within distinct 
populations.23,24
It is the present author’s view that the higher suscepti-
bility of O blood group individuals to H. pylori infection is 
most probably due to the higher frequency of secretor status 
in O blood group individuals.25 This view is supported by 
a previous demonstration, by Alkout et al, that H antigen 
represents an important receptor expressed in the gastroduo-
denal mucosal cells to which H. pylori adheres,20 which also 
enhances colonization of H. pylori bacteria.26
The support to the above view is that the ABH and 
Lewis (Le) antigens on the gastric and duodenal mucosa 
are synthesized through a specific glycosyltransferase from 
the basic H substance, and the O and Le (a− b+) phenotypes 
  (secretors) express a greater quantity of these basic fucosy-
lated antigens,27 in comparison with other groups, as Borén 
et al speculated later on.8
Blood group O individuals express a higher inflamma-
tory responses to H. pylori with higher levels of lymphocyte 
infiltration in the gastrointestinal mucusa,20,26,28 a lower level 
of Von Willebrand’s factor,29,30 and a higher frequency of 
secretor status;25 all these together, in the view of the present 
author, explain these individuals’ increased susceptibility to 
peptic ulceration.
Regarding Rh status, this present study showed no 
significant differences between the seropositive patients, 
seronegative patients, and the general population, which is 
in an agreement with previous studies.31
The prevalence of seropositivity will change between 
countries and within the same country, according to the 
socioeconomic status, being higher among groups with lower 
socioeconomic status.32,33 In this study, the prevalence of 
seropositivity to H. pylori infection was (64.8%) in symp-
tomatic patients in the Kurdistan region of Iraq, which is 
higher than the average prevalence in the world’s population 
(50%).34–36 It was in between the high prevalence in some 
developing countries (80%–90%) and the low prevalence 
in some developed countries (40%),37,38 eg, 35%–40% 
in the United States,39 while it was similar to those in the 
neighboring countries and some other countries, eg, Turkey40 
(68%), Saudi Arabia41 (61%), Kuwait42 (62%), some regions 
in Iran43,44 (66.7% to .85%), and Brazil23 (61.7%).
In this study, more females than males were seropositive 
(P = 0.0001), as seen by some other studies,9,39 while some 
other studies have noticed no such relation to gender31,32,40,42,43 
and some have even noticed a higher prevalence of H. pylori 
in men.45,46 The differences in socioeconomic conditions 
in the studied population and the type of controls used for 
comparison can explain this discrepancy.
Regarding acquisition of infection, the results of this 
study suggest that newly acquired H. pylori infections 
had happened during childhood and early adolescence, 
increasing to reach its peak at adulthood at 31 years with 
a median age of about 38 years (Figure 1). This present 
author’s observation was in concordance with many other 
authors’ findings.47–49
From various studies (including this one), genetic predis-
position, as well as environmental factors, are suggested as 
important influencing factors in H. pylori infection, a view 
supported by the Malaty and colleagues’ study on twins.50
Conclusion
From this study, which to date is the only study of this type 
in the Kurdistan region of Iraq, it can be concluded that 
H. pylori infection is an endemic problem, which should be 
dealt with by improving sanitation and purified water supply 
and also should be investigated for and eradicated. It can 
also be concluded that O blood group individuals are more 
susceptible to H. pylori infection and its symptomatic gastro-
intestinal complications, and/or they have more cellular and 
immunological response to it (expressed by seropositivity) 
than other ABO blood groups (group B in particular), while 
no significant differences between Rh+ and Rh− patients were 
seen. Also, it can be concluded that females and adolescents 
are more prone to H. pylori infection.
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